CUROSURF
Drug
Chiesi USA, Inc.
Total Payments
$2.5M
Transactions
5,009
Doctors
2,193
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $414,221 | 637 | 479 |
| 2023 | $275,863 | 592 | 442 |
| 2022 | $677,565 | 698 | 396 |
| 2021 | $334,516 | 525 | 364 |
| 2020 | $43,376 | 311 | 221 |
| 2019 | $209,030 | 689 | 351 |
| 2018 | $229,752 | 724 | 330 |
| 2017 | $266,317 | 833 | 418 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $837,792 | 160 | 34.2% |
| Grant | $461,475 | 37 | 18.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400,127 | 168 | 16.3% |
| Consulting Fee | $159,020 | 42 | 6.5% |
| Space rental or facility fees (teaching hospital only) | $134,319 | 147 | 5.5% |
| Food and Beverage | $119,070 | 2,887 | 4.9% |
| Travel and Lodging | $107,778 | 460 | 4.4% |
| Honoraria | $104,281 | 62 | 4.3% |
| Charitable Contribution | $56,150 | 32 | 2.3% |
| Education | $43,234 | 661 | 1.8% |
| Gift | $27,395 | 353 | 1.1% |
Payments by Type
General
$1.6M
4,849 transactions
Research
$837,792
160 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A STUDY IN PRETERM NEONATES WITH RDS TO COMPARE CUROSURF ADMINISTRATION THROUGH LISA AND CONVENTIONAL ADMINISTRATION (LISPAP) | CHIESI USA, INC. | $563,842 | 0 |
| A STUDY IN PRETERM NEONATES WITH RDS TO COMPARE CUROSURF ADMINISTRATION THROUGH LISA AND CONVENTIONAL ADMINISTRATION (LISPAP) | Chiesi USA, Inc. | $3,000 | 0 |
Top Doctors Receiving Payments for CUROSURF — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Louisville, KY | $516.25 | 5 |
| , M.D | Internal Medicine | Mobile, AL | $500.00 | 1 |
| , M.D | Neonatal-Perinatal Medicine | Chicago, IL | $478.98 | 9 |
| , MD | Neonatal-Perinatal Medicine | Livingston, NJ | $478.75 | 13 |
| , M.D | Pediatrics | Chicago, IL | $465.58 | 8 |
| , MD | Emergency Medicine | Berkeley Heights, NJ | $448.26 | 1 |
| , M.D | Neonatal-Perinatal Medicine | Chicago, IL | $429.62 | 6 |
| , M.D | Neonatal-Perinatal Medicine | New Orleans, LA | $413.55 | 10 |
| , MD | Neonatal-Perinatal Medicine | Newark, NJ | $393.68 | 9 |
| , M.D | Neonatal-Perinatal Medicine | Springfield, MA | $382.93 | 5 |
| , M.D | Neonatal-Perinatal Medicine | Corpus Christi, TX | $369.18 | 5 |
| , MD | Neonatal-Perinatal Medicine | Oklahoma City, OK | $364.20 | 4 |
| , MD | Neonatal-Perinatal Medicine | Coppell, TX | $353.55 | 3 |
| , MD | Neonatal-Perinatal Medicine | Orlando, FL | $353.44 | 5 |
| , MD | Neonatal-Perinatal Medicine | Valhalla, NY | $347.76 | 5 |
| , MD | Neonatal-Perinatal Medicine | Stony Brook, NY | $337.99 | 3 |
| , MD | Neonatal-Perinatal Medicine | Stony Brook, NY | $337.99 | 3 |
| , MD | Pediatrics | Los Angeles, CA | $333.50 | 7 |
| , MD | Neonatal-Perinatal Medicine | Springfield, MA | $328.99 | 4 |
| , M.D | Pediatrics | New York, NY | $323.41 | 4 |
| , M.D | Neonatal-Perinatal Medicine | Saint Louis, MO | $323.26 | 2 |
| , M.D | Pediatrics | Augusta, GA | $320.48 | 13 |
| , M.D | Neonatal-Perinatal Medicine | Saint Louis, MO | $319.45 | 2 |
| , MBBS | Neonatal-Perinatal Medicine | Augusta, GA | $318.36 | 9 |
| , D.O | Neonatal-Perinatal Medicine | Macon, GA | $313.54 | 12 |
Ad
Manufacturing Companies
- Chiesi USA, Inc. $1.5M
- CHIESI USA, INC. $910,741
Product Information
- Type Drug
- Total Payments $2.5M
- Total Doctors 2,193
- Transactions 5,009
About CUROSURF
CUROSURF is a drug associated with $2.5M in payments to 2,193 healthcare providers, recorded across 5,009 transactions in the CMS Open Payments database. The primary manufacturer is Chiesi USA, Inc..
Payment data is available from 2017 to 2024. In 2024, $414,221 was paid across 637 transactions to 479 doctors.
The most common payment nature for CUROSURF is "Unspecified" ($837,792, 34.2% of total).
CUROSURF is associated with 2 research studies, including "A STUDY IN PRETERM NEONATES WITH RDS TO COMPARE CUROSURF ADMINISTRATION THROUGH LISA AND CONVENTIONAL ADMINISTRATION (LISPAP)" ($563,842).